Medication adherence, compliance and persistence are closely related terms, but all require the involvement of an active patient in order to be successful, according to David Nau, senior director of research and performance measurement at the Pharmacy Quality Alliance (PQA).


Medication adherence, David Nau, Pharmacy Quality Alliance, PQA, health care, Rite Aid, National Association of Chain Drug Stores Pharmacy and Technology Conference, Rich Mohall, clinical services, pharmacies, patient health, health and wellness, medication therapy management, MTM, Highmark Blue Shield, CECity.com, pharmacy services, John Schultz, New England Healthcare Institute, electronic prescribing, chronic care medications








































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Inside This Issue - News

Medication adherence: Active patient key to care

September 27th, 2010

SAN DIEGO – Medication adherence, compliance and persistence are closely related terms, but all require the involvement of an active patient in order to be successful, according to David Nau, senior director of research and performance measurement at the Pharmacy Quality Alliance (PQA).

The alliance is represented by a group of diverse health care stakeholders committed to improving health care quality and patient safety by defining pharmacy performance measures that improve medication use and medication-related services.

During an educational session at the National Association of Chain Drug Stores Pharmacy and Technology Conference last month, Nau and Rick Mohall, director of clinical services at Rite Aid Corp., outlined several of the innovative approaches that pharmacies and health care groups have been following to improve medication adherence and patient health.

Pharmacies, through their position as health and wellness destinations for the public, are key providers of compliance and adherence programs, pointed out Mohall, whose current role gives him responsibility for medication therapy management (MTM) and other programs at Rite Aid.

“We continue to develop programs to increase compliance and adherence,’’ he said, explaining that Rite Aid’s services in this area include its wellness+ loyalty program, medication therapy management, automated courtesy prescription refills and reminder calls. “This approach is a win-win-win for our patients, for pharmaceutical companies and for our bottom line.

“Our loyalty card program incents customers to fill their prescriptions, our refill program also allows our pharmacists to monitor compliance, and our MTM program provides patients with complex therapies an opportunity to measure adherence and outcomes,” Mohall explained.

In one initiative, Rite Aid has forged a PQA partnership with Highmark Blue Shield, a large regional health plan based in western Pennsylvania, and CECity.com, a technology partner, to improve the quality of pharmacy services.

Under the alliance, Rite Aid’s pharmacists have been trained to understand the compliance and adherence measurements in the PQA program, and the pharmacists have been provided with tools leading to patient interventions to ensure that they understand the importance of compliance and adherence. The initiative is slated to lead to pharmacist reimbursement for those services.

Originally involving 54 Rite Aid locations in western Pennsylvania, the project has since been expanded to 240 stores so that pharmacists can compare their efforts with those of their colleagues.

To increase adherence, Mohall said, pharmacists should ask patients such questions as whether they feel their medications are doing more harm than good, whether they understand how their medicines can improve their health and whether filling their prescriptions presents them with a financial burden.

Lack of medication, noted Nau, has been cited as “America’s other drug problem.’’ It has contributed to progression of disease and complications that have led to lower quality of life and even death. A higher adherence rate, he added, most often results in reduced rates for hospitals and total medical spending.

Employers are increasingly analyzing prescription data to examine such factors as the impact on productivity and the effect that nonadherence has on their total health care expenditures, explained Nau, He cited figures from the New England Healthcare Institute showing that a typical midsize employer with $10 million in annual claims might waste over $1 million because of nonadherence.

Efforts that Nau said have been attempted to increase adherence include electronic prescribing and reducing health plan members’ costs for chronic care medications.

Advertisement